Phase 2 Preterm Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2Phase 3
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial
developmental delayGingivitisPeriodontitis+2 more
University of Washington6,000 enrolled1 locationNCT07424846
Recruiting
Phase 2
MINImising Total Radiation EXposure in Preterm Infants
neonatal respiratory distress syndromePreterm neonate
Western Health, Australia180 enrolled1 locationNCT06975189
Recruiting
Phase 2
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
PretermTransient; Hypoglycemia, NeonatalGlibenclamide Adverse Reaction
Assistance Publique - Hôpitaux de Paris35 enrolled1 locationNCT05687500
Recruiting
Phase 2
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
Preterm Birth
Rutgers, The State University of New Jersey50 enrolled1 locationNCT05703425
Recruiting
Phase 2
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
PretermPatent Ductus Arteriosus
Hamilton Health Sciences Corporation26 enrolled1 locationNCT07143201
Recruiting
Phase 1Phase 2
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
PreeclampsiaPreterm Birth
Thomas Jefferson University400 enrolled1 locationNCT06826859
Not Yet Recruiting
Phase 2Phase 3
Autologous cord blood-derived cell therapy for extremely preterm infants: An international, multicentre randomised controlled trial
preterm brain injury
Monash Health334 enrolled3 locationsACTRN12624000968572
Completed
Phase 2Phase 3
The safety and efficacy of a locally available probiotic in premature infants.
all cause mortality and time to full feeds in preterm very low birthweight neonatesNecrotising Enterocolitis
Womens and Childrens Health Service120 enrolled1 locationACTRN12609000374268